Veterinary Medicines

Nobilis ND Clone 30

Authorised
  • Newcastle disease virus, strain Clone 30, Live
Download as PDF

Product identification

Medicine name:
Nobilis ND Clone 30
Active substance:
  • Newcastle disease virus, strain Clone 30, Live
Target species:
  • Turkey
  • Chicken
Route of administration:
  • Nebulisation use
  • Intraocular use
  • Nasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Nebulisation use
    • Turkey
      • Meat and offal
        0
        day
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
  • Intraocular use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
  • Nasal use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 490a/93
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 30/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."